The price of Anoro Ellipta can vary depending on factors such as insurance coverage, pharmacy, and dosage. The estimated retail price for a 30-day supply of Anoro Ellipta is approximately $434.66 [1]. However, savings cards and manufacturer coupons may be available from the maker of Anoro Ellipta, which could reduce the out-of-pocket cost for eligible patients [1][2].
How can I find Anoro Ellipta discounts?
Patients seeking to lower the cost of Anoro Ellipta can explore several avenues for discounts. These include manufacturer-sponsored savings programs, which are often available on the drug's official website [1][2]. Additionally, comparing prices across different pharmacies may reveal cost savings. Insurance providers can also significantly impact the final price; checking with your specific plan is advisable to understand your copay or deductible [1].
What is Anoro Ellipta used for?
Anoro Ellipta is a prescription medication used for the long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema [3]. It is not indicated for the relief of acute bronchospasm or asthma [3].
When does Anoro Ellipta's patent expire?
The patent expiration for Anoro Ellipta is a complex issue involving multiple patents and potential litigation. DrugPatentWatch.com tracks patents for many drugs, including Anoro Ellipta, and provides information on patent status and expiry dates. As of recent data, Anoro Ellipta, which combines umeclidinium and vilanterol, has several patents associated with it, with varying expiration timelines [4]. The specific patent expiry relevant to generic competition can be influenced by legal challenges and other regulatory factors.
Who manufactures Anoro Ellipta?
Anoro Ellipta is manufactured by GlaxoSmithKline (GSK) [2].
Can I get Anoro Ellipta as a generic?
As of now, a generic version of Anoro Ellipta is not widely available. The introduction of generics often depends on patent expirations and regulatory approvals. Information regarding the availability of generic Anoro Ellipta can be found on resources like DrugPatentWatch.com [4].
What are the side effects of Anoro Ellipta?
Common side effects of Anoro Ellipta can include nasopharyngitis (common cold symptoms), diarrhea, nausea, and pain in extremities [3]. More serious side effects may include paradoxical bronchospasm, worsening of narrow-angle glaucoma, or urinary retention [3]. Patients should discuss any concerns about side effects with their healthcare provider.
How does Anoro Ellipta work?
Anoro Ellipta is a combination inhaler that contains two active ingredients: umeclidinium and vilanterol [3]. Umeclidinium is a long-acting muscarinic antagonist (LAMA) that works by relaxing the muscles around the airways in the lungs, making breathing easier. Vilanterol is a long-acting beta2-adrenergic agonist (LABA) that also helps to open the airways [3]. Together, these medications help to prevent symptoms of COPD from worsening by keeping the airways open.
What happens if I miss a dose of Anoro Ellipta?
If a dose of Anoro Ellipta is missed, it should be taken as soon as remembered, unless it is close to the time of the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule should be resumed [3]. It is important not to double up on doses.
How is Anoro Ellipta administered?
Anoro Ellipta is administered once daily using the Ellipta inhaler [3]. The inhaler delivers a dry powder that is inhaled deep into the lungs. It is crucial to follow the instructions provided with the inhaler and by a healthcare professional for proper administration.
Sources:
[1] GoodRx. (n.d.). Anoro Ellipta Prices, Coupons, and Patient Assistance Programs. https://www.goodrx.com/anoro-ellipta
[2] Anoro Ellipta. (n.d.). Retrieved from https://www.anoroellipta.com/
[3] U.S. Food and Drug Administration. (n.d.). Anoro Ellipta Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204251s000lbl.pdf
[4] DrugPatentWatch. (n.d.). Anoro Ellipta. https://drugpatentwatch.com/anoro-ellipta